[1]CurrentPatentAssignee:GLAXOSMITHKLINEPLC-US9346840,2016,B2Locationinpatent:Page/Pagecolumn77
[1]PLoSONE,2017,vol.12
1306604-68-1
1463-08-7
771583-34-7
1039932-36-9
1208915-57-4
862992-93-6 | 2-(Benzyloxy)-3-bromobenzonitrile | AA00H3E5 | MFCD28128126
89642-17-1 | 2-Bromo-1-chloro-3-methyl-5-nitrobenzene | AA00H4CB | MFCD28130130
925920-82-7 | 2-methyl-5-(4-morpholinylmethyl)benzenamine | AA00H56Q | MFCD10021456
667917-13-7 | 1,3,2-Dioxaborolane, 2-(3-methoxypropyl)-4,4,5,5-tetramethyl- | AA00H5Z2 | MFCD24369091
943735-44-2 | 2,5-Dibromothiazole-4-carboxylic acid | AA00H7Q5 | MFCD10001381
63659-19-8 | Betaxolol hydrochloride | AA00H8VX | MFCD01319152
100886-56-4 | 3-Butanoyl-8-methoxy-2h-chromen-2-one | AA00H9AK | MFCD18203429
1023299-41-3 | 2-(1H-Indazol-1-yl)thiazole-4-carboxylic acid | AA00H9P7 | MFCD29059434
1033693-19-4 | 3-Methyl-2-(methylthio)phenol | AA00H9Z6 | MFCD10686635
104370-29-8 | (Triphenylmethyl)hydrazine hydrochloride | AA00HA9H | MFCD00403938